[1]Bosch FX, Ribes J, Diaz M, et al.Primary liver cancer: worldwide incidence and trends[J]. Gastroenterology,2004,127:S5-S16. [2]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017,67:7-30. [3]Villanueva A, Hernandez-Gea V, Llovet JM. Medical therapies for hepatocellular carcinoma: a critical view of the evidence[J]. Nat Rev Gastroenterol Hepatol, 2013,10:34-42. [4]Dong R, Liu XQ, Zhang BB, et al. Long non-coding RNA-CRNDE: a novel regulator of tumor growth and angiogenesis in hepatoblastoma[J].Oncotarget, 2017,8:42087-42097. [5]Xia XL, Xue D, Xiang TH, et al. Overexpression of long non coding RNA CRNDE facilitates epithelial mesenchymal transition and correlates with poor prognosis in intrahepatic cholangiocarcinoma[J].Oncol Lett, 2018, 15:4105-4112. [6]Zhu L,Liu Y, Chen Q, et al. Long-noncoding RNA colorectal neoplasia differentially expressed gene as a potential target to upregulate the expression of IRX5 by miR-136-5P to promote oncogenic properties in hepatocellular carcino-ma[J]. Cell Physiol Biochem, 2018,50:2229-2248. [7]Graham LD, Pedersen SK, Brown GS, et al. Colorectal neoplasia differentially expressed (CRNDE), a novel gene with elevated expression in colorectal adenomas and adenocarcinomas[J]. Genes Cancer, 2011,2:829-840. [8]Li DX,Fei XR,Dong YF, et al. The long non-coding RNA CRNDE acts as a ceRNA and promotes glioma malignancy by preventing miR-136-5p-mediated downregula-tion of Bcl-2 and Wnt2[J]. Oncotarget, 2017, 8:88163-88178. [9]Huan J, Xing L, Lin Q, et al. Long noncoding RNA CRNDE activates Wnt/β-catenin signaling pathway through acting as a molecular sponge of microRNA-136 in human breast cancer[J]. Am J Transl Res, 2017,9:1977-1989. [10]Dai MY, Chen SY, Wei XM, et al. Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma[J].Oncotarget, 2017,8:95799-95809. [11]Wan L, Zhang D, Zhang J, et al. TT-1, an analog of melittin, tirggers apoptosis in human thyroid cancer TT cells via regulating caspase, Bcl-2 and Bax[J]. Oncol Lett, 2018,15:1271-1278. [12]Cory S, Huang DC, Adams JM. The Bcl-2 faminly: roles in cell survival and oncogenesis[J].Oncogene, 2003,8590-8607. [13]洪坚善,彭浩,段小娴. E-cadherin的表达与肝细胞癌侵袭和转移的关系[J].基础医学与临床,2005,25:1139-1142. [14]Wellner U,Schubert J,Burk UC,et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs[J].Nat Cell Biol,2009, 11: 1487-1495. |